Nu Skin Enterprises (NYSE:NUS) Announces Quarterly Earnings Results

Nu Skin Enterprises (NYSE:NUSGet Free Report) released its quarterly earnings data on Monday. The company reported $0.20 EPS for the quarter, meeting the consensus estimate of $0.20, FiscalAI reports. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. The business had revenue of $320.11 million during the quarter, compared to analyst estimates of $345.20 million. Nu Skin Enterprises updated its FY 2026 guidance to 0.700-0.900 EPS and its Q3 2026 guidance to 0.100-0.200 EPS.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

  • Second-quarter revenue was $320.1 million, including a $4 million foreign-currency headwind, while adjusted EPS was near the midpoint of guidance. Adjusted operating margin declined to 6.1% from 8.0% year over year.
  • Prysm iO adoption continued to build, with more than 39,000 devices placed—up nearly 30% quarter over quarter—and 2.5 million scans. Nu Skin expects 50,000–60,000 placements by year-end and plans to launch an AI-enabled app to improve personalization, conversion, and customer engagement.
  • Nu Skin delayed the formal India market launch to the first half of 2027 while it refines local manufacturing, logistics, technology integration, and the affiliate business model.
  • Management said recruiting and leadership development remain below the levels needed for sustainable growth, while affiliates are still adapting to selling the wellness-focused Prysm iO product rather than the company’s historically stronger beauty offerings.
  • Full-year guidance now calls for revenue of $1.28 billion–$1.35 billion and adjusted EPS of $0.70–$0.90. Reported results included a $78.9 million goodwill impairment and a $167.5 million deferred-tax valuation allowance, while the planned East-West restructuring is expected to incur $5 million–$10 million in cash transition costs.

Nu Skin Enterprises Trading Down 6.0%

NUS stock traded down $0.33 during mid-day trading on Monday, reaching $5.16. 1,116,925 shares of the stock traded hands, compared to its average volume of 596,442. Nu Skin Enterprises has a one year low of $4.89 and a one year high of $14.62. The stock has a market capitalization of $250.52 million, a PE ratio of 4.69 and a beta of 0.98. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.34 and a current ratio of 2.03. The business has a 50-day moving average price of $5.22 and a two-hundred day moving average price of $6.98.

Hedge Funds Weigh In On Nu Skin Enterprises

Several hedge funds have recently added to or reduced their stakes in NUS. Corient Private Wealth LLC purchased a new stake in Nu Skin Enterprises in the 4th quarter worth about $166,000. Invesco Ltd. boosted its position in shares of Nu Skin Enterprises by 15.9% during the fourth quarter. Invesco Ltd. now owns 85,975 shares of the company’s stock valued at $827,000 after buying an additional 11,810 shares during the period. State of Tennessee Department of Treasury boosted its position in shares of Nu Skin Enterprises by 165.2% during the fourth quarter. State of Tennessee Department of Treasury now owns 30,835 shares of the company’s stock valued at $327,000 after buying an additional 19,210 shares during the period. EP Wealth Advisors LLC bought a new position in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $692,000. Finally, Empowered Funds LLC grew its stake in shares of Nu Skin Enterprises by 45.0% during the fourth quarter. Empowered Funds LLC now owns 241,670 shares of the company’s stock valued at $2,325,000 after buying an additional 74,945 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on NUS. Zacks Research upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Weiss Ratings lowered Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of “Reduce”.

Get Our Latest Report on Nu Skin Enterprises

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

Featured Stories

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.